HCW Biologics .
Agent40Agent Readiness: 40/100. Below median. Measured by StartupHub.ai. Median 41.Trust82Data Trust: 82/100. Top 25%. Measured by StartupHub.ai. Median 61.Developing transformative fusion immunotherapeutics for autoimmune diseases, cancer, and senescence-associated dysplasia.
About
HCW Biologics is a biotechnology company focused on developing novel fusion protein therapeutics. Their platform aims to create revolutionary treatments for a range of challenging diseases, including autoimmune disorders, cancer, and conditions associated with aging like senescence-associated dysplasia.
Listed competitors
Biopharmaceutical company focused on developing and commercializing innovative medicines.
A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
A biotechnology company that invents, develops, manufactures, and commercializes medicines for serious diseases.
Also in this space
Developing engineered biologics to harness the immune system for disease treatment.
Shares Biotech, Drug Discovery
Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.
Shares Biotech, Longevity
Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
Shares Biotech, Autoimmune Diseases
Biotech company focused on developing therapies to extend human healthspan and lifespan.
Shares Biotech, Longevity
BioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.
Shares Biotech, Longevity
Biotechnology company developing novel therapeutics to promote healthy longevity by understanding aging pathways.
Shares Biotech, Longevity
Key facts
- Website
- hcwbiologics.com
- Headquarters
- Miramar, United States
- Founded
- 2017
- Business model
- B2B
Tech stack
Detected on hcwbiologics.com, last scanned 31 Oct 2026. Run your own scan
- Frontend
- jQuery
- SEO
- Rank Math
- CMS / Builders
- WordPress
- Hosting
- Google Cloud
- Email provider
- Barracuda
HCW Biologics . scores 31. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
5 reviews from Reddit gathered in one place
This filing concerns the resale of up to 5.7M shares of common stock by selling stockholders. The company is a clinical-stage biopharmaceutical firm developing fusion immunotherapeutics.
HCW Biologics registered shares for resale from a $4.0 million private placement, which included $600,000 from insiders, providing crucial capital amidst financial distress and Nasdaq compliance issues, though it comes with significant pote…
HCW Biologics Inc. received an extension from Nasdaq to regain compliance with the minimum $1 bid price rule, requiring demonstration by July 29, 2026, subject to conditions including a potential one-year Panel Monitor.
HCW Biologics CEO Hing C. Wong purchased $160,000 of company stock in a private placement, signaling strong conviction despite recent financial challenges and a pending dilutive offering.
HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen.
Each quote is copied word for word and links to where it was posted. Promotion and off-topic posts are filtered out.
Frequently asked
Is HCW Biologics . trustworthy and reputable?
StartupHub's Data Trust & Reputation score for HCW Biologics . is 82 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for HCW Biologics .
